---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-001222"
form_type: "8-K"
ticker: "TARA"
cik: "0001359931"
company_name: "Protara Therapeutics, Inc."
filed_at: "2022-01-10T23:59:59+00:00"
generated_at: "2026-06-27T19:16:48.193274+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Protara Therapeutics appoints Jathin Bandari as Chief Medical Officer

## Summary
- Dr. Bandari, previously Interim CMO, appointed permanent CMO effective Jan 10, 2022.
- Annual base salary of $415,000, discretionary bonus target 40% of base.
- Granted stock option for 81,000 shares and RSU for 13,500 shares, subject to board approval.
- Severance: 9 months salary plus target bonus and healthcare if terminated without cause or for good reason.
- In change of control termination, 100% acceleration of unvested equity.

## SEC filing metadata
- accession: 0001213900-22-001222
- form_type: 8-K
- ticker: TARA
- cik: 0001359931
- company_name: Protara Therapeutics, Inc.
- filed_at: 2022-01-10T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1359931/000121390022001222/0001213900-22-001222-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1359931/000121390022001222/ea153715-8k_protarathera.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-001222
- JSON: https://secwatch.observer/filing/0001213900-22-001222.json
- Plain text: https://secwatch.observer/filing/0001213900-22-001222.txt

## Key facts
- Executive change
  Jathin Bandari was appointed as Chief Medical Officer at Protara Therapeutics, Inc..
  - Action: appointed
  - Role: Chief Medical Officer
  source text: Effective as of January 10, 2022 (the “Effective Date”), Protara Therapeutics, Inc. (the “Company”) appointed Jathin Bandari, M.D. as Chief Medical Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1359931/000121390022001222/0001213900-22-001222-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.